CLARIANE SE (CLARI.PA) Stock Fundamental Analysis
Europe - EPA:CLARI - FR0010386334 - Common Stock
3.428 EUR
-0.03 (-0.98%)
CLARI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 27 industry peers in the Health Care Providers & Services industry. CLARI may be in some trouble as it scores bad on both profitability and health. CLARI has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
CLARI had negative earnings in the past year.
In the past year CLARI had a positive cash flow from operations.
In multiple years CLARI reported negative net income over the last 5 years.
In the past 5 years CLARI always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of CLARI (-0.43%) is worse than 77.78% of its industry peers.
With a Return On Equity value of -1.71%, CLARI is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 1.63%, CLARI is doing worse than 81.48% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CLARI is below the industry average of 6.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.43% | ||
| ROE | -1.71% | ||
| ROIC | 1.63% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
1.3 Margins
CLARI has a Operating Margin (4.80%) which is in line with its industry peers.
CLARI's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 91.90%, CLARI belongs to the best of the industry, outperforming 96.30% of the companies in the same industry.
In the last couple of years the Gross Margin of CLARI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.8% | ||
| PM (TTM) | N/A | ||
| GM | 91.9% |
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CLARI is destroying value.
The number of shares outstanding for CLARI has been increased compared to 1 year ago.
Compared to 5 years ago, CLARI has more shares outstanding
The debt/assets ratio for CLARI has been reduced compared to a year ago.
2.2 Solvency
CLARI has an Altman-Z score of 0.62. This is a bad value and indicates that CLARI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.62, CLARI is doing worse than 81.48% of the companies in the same industry.
The Debt to FCF ratio of CLARI is 13.25, which is on the high side as it means it would take CLARI, 13.25 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 13.25, CLARI is doing worse than 66.67% of the companies in the same industry.
A Debt/Equity ratio of 1.90 is on the high side and indicates that CLARI has dependencies on debt financing.
The Debt to Equity ratio of CLARI (1.90) is worse than 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 13.25 | ||
| Altman-Z | 0.62 |
ROIC/WACC0.44
WACC3.72%
2.3 Liquidity
A Current Ratio of 0.67 indicates that CLARI may have some problems paying its short term obligations.
The Current ratio of CLARI (0.67) is worse than 77.78% of its industry peers.
A Quick Ratio of 0.65 indicates that CLARI may have some problems paying its short term obligations.
CLARI has a worse Quick ratio (0.65) than 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.65 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 84.49% over the past year.
The Revenue has been growing slightly by 2.70% in the past year.
CLARI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.89% yearly.
EPS 1Y (TTM)84.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%
3.2 Future
The Earnings Per Share is expected to grow by 39.56% on average over the next years. This is a very strong growth
CLARI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.04% yearly.
EPS Next Y170.47%
EPS Next 2Y86.53%
EPS Next 3Y58.66%
EPS Next 5Y39.56%
Revenue Next Year2.57%
Revenue Next 2Y3.2%
Revenue Next 3Y3.58%
Revenue Next 5Y4.04%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CLARI. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 9.46, the valuation of CLARI can be described as very reasonable.
Based on the Price/Forward Earnings ratio, CLARI is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.35. CLARI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.46 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLARI indicates a somewhat cheap valuation: CLARI is cheaper than 62.96% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CLARI is valued cheaper than 96.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.98 | ||
| EV/EBITDA | 8.31 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLARI's earnings are expected to grow with 58.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.53%
EPS Next 3Y58.66%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 10.64%, CLARI is a good candidate for dividend investing.
In the last 3 months the price of CLARI has falen by -20.16%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 2.55, CLARI pays a better dividend. On top of this CLARI pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, CLARI pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
5.2 History
The dividend of CLARI decreases each year by -7.26%.
Dividend Growth(5Y)-7.26%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of CLARI are negative and hence is the payout ratio. CLARI will probably not be able to sustain this dividend level.
DP-110.43%
EPS Next 2Y86.53%
EPS Next 3Y58.66%
EPA:CLARI (11/6/2025, 4:03:19 PM)
3.428
-0.03 (-0.98%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.41%
Inst Owner ChangeN/A
Ins Owners5.63%
Ins Owner ChangeN/A
Market Cap1.22B
Revenue(TTM)5.31B
Net Income(TTM)-61380000
Analysts77.14
Price Target4.74 (38.27%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
Yearly Dividend0.19
Dividend Growth(5Y)-7.26%
DP-110.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.89%
PT rev (3m)3.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)23.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.46 | ||
| P/S | 0.23 | ||
| P/FCF | 1.98 | ||
| P/OCF | 1.39 | ||
| P/B | 0.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.31 |
EPS(TTM)-0.17
EYN/A
EPS(NY)0.36
Fwd EY10.57%
FCF(TTM)1.73
FCFY50.53%
OCF(TTM)2.47
OCFY72.18%
SpS14.88
BVpS10.05
TBVpS-5.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.43% | ||
| ROE | -1.71% | ||
| ROCE | 2.21% | ||
| ROIC | 1.63% | ||
| ROICexc | 1.74% | ||
| ROICexgc | 3.53% | ||
| OM | 4.8% | ||
| PM (TTM) | N/A | ||
| GM | 91.9% | ||
| FCFM | 11.64% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexgc growth 3Y-9.02%
ROICexgc growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score6
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 13.25 | ||
| Debt/EBITDA | 6.54 | ||
| Cap/Depr | 33.63% | ||
| Cap/Sales | 4.99% | ||
| Interest Coverage | 0.83 | ||
| Cash Conversion | 84.71% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.65 | ||
| Altman-Z | 0.62 |
F-Score6
WACC3.72%
ROIC/WACC0.44
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
EPS Next Y170.47%
EPS Next 2Y86.53%
EPS Next 3Y58.66%
EPS Next 5Y39.56%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%
Revenue Next Year2.57%
Revenue Next 2Y3.2%
Revenue Next 3Y3.58%
Revenue Next 5Y4.04%
EBIT growth 1Y-22.25%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year302.5%
EBIT Next 3Y65.72%
EBIT Next 5Y38.3%
FCF growth 1Y267.6%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.15%
OCF growth 3Y2.33%
OCF growth 5Y3.29%
CLARIANE SE / CLARI.PA FAQ
What is the ChartMill fundamental rating of CLARIANE SE (CLARI.PA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CLARI.PA.
What is the valuation status for CLARI stock?
ChartMill assigns a valuation rating of 6 / 10 to CLARIANE SE (CLARI.PA). This can be considered as Fairly Valued.
What is the profitability of CLARI stock?
CLARIANE SE (CLARI.PA) has a profitability rating of 3 / 10.
How sustainable is the dividend of CLARIANE SE (CLARI.PA) stock?
The dividend rating of CLARIANE SE (CLARI.PA) is 5 / 10 and the dividend payout ratio is -110.43%.